A new DNA test that lets you see your risk of diseases like cancer could compete with 23andMe — here’s how it differs

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A new DNA test from Helix looks at the impact of genetic variants on your risk of diseases such as breast cancer, colon cancer, and high cholesterol.

You can buy the test online for $260, but it must be approved by a physician.

Available online, the test looks at the impact of several dozen genetic variants on your risk of diseases such as breast cancer, colon cancer, and high cholesterol. "This is potentially very heavy information," Elissa Levin, Helix's senior director of clinical affairs, told Business Insider."We're not glossing over it."Color Genomics

The new test looks at 59 genetic variants that are considered"medically actionable," as defined by the American College of Medical Genetics and Genomics. While a positive result with the new test suggests that someone has a significantly higher risk of a disease like breast cancer, a negative result does not necessarily signify that they are free from risk or at a low risk.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in HEALTH

Health Health Latest News, Health Health Headlines